CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 45 enrolled
Drug / intervention
Ketamine +1 moredrug
Likely dose
Ketamine 0.3 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01538745
NCT01538745Phase 4Completed

Low Dose Ketamine (LDK) Versus Morphine for Acute Pain Control in the Emergency Department

Brooke Army Medical Center·interventional·Posted Feb 24, 2012·Updated Feb 4, 2021

In Brief

A Phase 4 clinical trial evaluating Ketamine and Morphine for Abdomen, Acute and 4 related conditions. Completed, enrolled 45 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the safety and effectiveness of intravenous low dose ketamine (LDK) to the industry standard of morphine (MOR) in regards to controlling acute pain in the emergency department. Both LDK and morphine have side effects. The amount and character of these side effects will be compared. Additionally, the degree of sedation or agitation will be specifically measured. The aim of this current study is to make this comparison and shift the evidence for LDK use from the anecdotal to the scientific.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 24, 2012
Enrollment StartFeb 1, 2012
Primary CompletionMar 1, 2013
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 14.4 years ago

Interventions

Ketaminedrug

0.3 mg/kg ketamine Intravenous push (IVP) over 5 minutes. Total of two possible doses.

Morphinedrug

0.1 mg/kg Morphine IVP over 5 minutes. Total of two possible doses.